I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Boccaccino, A
103
results:
Search for persons
X
Format
Online (103)
Mediatypes
Articles (Online) (42)
OpenAccess-fulltext (61)
Sorted by: Relevance
Sorted by: Year
?
1
Treatment of patients with BRAF-mutated metastatic colorect..:
Germani, M.M.
;
Vetere, G.
;
Santamaria, F.
...
ESMO Open. 9 (2024) 4 - p. 102996 , 2024
Link:
https://doi.org/10.1016/..
?
2
293P Durvalumab plus gemcitabine and cisplatin in advanced ..:
Gardini, A. Casadei
;
Fornaro, L.
;
Lonardi, S.
...
Annals of Oncology. 35 (2024) - p. S124 , 2024
Link:
https://doi.org/10.1016/..
?
3
158TiP Exploiting circulating tumor DNA (ctDNA) to intensif..:
Conca, V.
;
Vetere, G.
;
Moretto, R.
...
Annals of Oncology. 35 (2024) - p. S70 , 2024
Link:
https://doi.org/10.1016/..
?
4
Phase II study of capecitabine-based concomitant chemoradia..:
Grassi, E.
;
Zingaretti, C.
;
Petracci, E.
...
ESMO Open. 8 (2023) 5 - p. 101824 , 2023
Link:
https://doi.org/10.1016/..
?
5
Plasmatic BRAF-V600E allele fraction as a prognostic factor..:
Ros, J.
;
Matito, J.
;
Villacampa, G.
...
Annals of Oncology. 34 (2023) 6 - p. 543-552 , 2023
Link:
https://doi.org/10.1016/..
?
6
Encorafenib plus cetuximab with or without binimetinib in p..:
Boccaccino, A.
;
Borelli, B.
;
Intini, R.
...
ESMO Open. 7 (2022) 3 - p. 100506 , 2022
Link:
https://doi.org/10.1016/..
?
7
Prognostic and predictive impact of consensus molecular sub..:
Borelli, B.
;
Fontana, E.
;
Giordano, M.
...
ESMO Open. 6 (2021) 2 - p. 100073 , 2021
Link:
https://doi.org/10.1016/..
?
8
Clinical impact of neutropenia and febrile neutropenia in m..:
Rossini, D.
;
Boccaccino, A.
;
Sbrana, A.
...
ESMO Open. 6 (2021) 6 - p. 100293 , 2021
Link:
https://doi.org/10.1016/..
?
9
Molecular screening with liquid biopsy for anti-EGFR retrea..:
Germani, Marco Maria
;
Vetere, Guglielmo
;
Giordano, Mirella
...
Frontiers in Oncology. 13 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
10
Exploring the Outcome of Disappearance or Small Remnants of..:
Boraschi, Piero
;
Moretto, Roberto
;
Donati, Francescamaria
...
Cancers. 15 (2023) 8 - p. 2200 , 2023
Link:
https://doi.org/10.3390/..
?
11
Adverse events during first-line treatments for mCRC: The T..:
Boccaccino, Alessandra
;
Rossini, Daniele
;
Raimondi, Alessandra
...
European Journal of Cancer. 189 (2023) - p. 112910 , 2023
Link:
https://doi.org/10.1016/..
?
12
Primary tumour side as a driver for treatment choice in RAS..:
Rossini, Daniele
;
Boccaccino, Alessandra
;
Carullo, Martina
...
European Journal of Cancer. 184 (2023) - p. 106-116 , 2023
Link:
https://doi.org/10.1016/..
?
13
Dissecting tumor lymphocyte infiltration to predict benefit..:
Moretto, Roberto
;
Rossini, Daniele
;
Catteau, Aurélie
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 4 - p. e006633 , 2023
Link:
https://doi.org/10.1136/..
?
14
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derive..:
Borelli, Beatrice
;
Crucitta, Stefania
;
Boccaccino, Alessandra
...
Tumori Journal. 109 (2023) 5 - p. 481-489 , 2023
Link:
https://doi.org/10.1177/..
?
15
Tumour mutational burden predicts resistance to EGFR/BRAF b..:
Randon, Giovanni
;
Intini, Rossana
;
Cremolini, Chiara
...
European Journal of Cancer. 161 (2022) - p. 90-98 , 2022
Link:
https://doi.org/10.1016/..
1-15